Publication Cover
Materials Technology
Advanced Performance Materials
Volume 37, 2022 - Issue 11
170
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Biogenically engineered silver nanoparticles using bael leaf extract and evaluation of its therapeutic potential

ORCID Icon, , , ORCID Icon, , , , , , & show all
Pages 1617-1628 | Received 17 Jan 2021, Accepted 02 Aug 2021, Published online: 12 Aug 2021
 

ABSTRACT

The current study aims to explore the antimicrobial and anticancer activity of biogenic silver nanoparticles (B-AgNPs) synthesized using Bael leaf extract. AgNPs nanoparticles characterized using FESEM, TEM, XRD, and UV-Spectrophotometry. TEM analysis revealed that B-AgNPs were predominantly spheroidal with particle size distribution in the range of 7-10 nm. In MTT assay, when B-AgNPs were applied in colon cancer (HCT-116) cells and human colon epithelial cell line (FHC) cells. B-AgNPs exhibited specific cytotoxicity to HCT-116 as minimal effect observed in normal FHC cells. Moreover, the fluorescence microscopic examination after nucleus staining as well as DNA fragmentation also confirmed AgNPs spectific cytotoxicity towards HCT-116. Further, AgNPs demonstrated excellent antibiofilm and antibacterial activity in both Gram-Positive and Gram-negative bacteria. Hence, overall, we categorically concluded that the biogenic silver nanoparticles synthesized using Bael leaf extract possess multiple biological activities and might be possibly used as multipurpose therapeutic material with no or little systemic toxicity.

Acknowledgments

The authors sincerely thank Karunya Institute of Technology and Sciences (Deemed-to-be University) for their support, encouragement, and for extending all the necessary facilities in the university.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.